News

Biotime news

Exhibition

BIOTIME SARS-CoV-2 IgG/IgM Rapid Qualitative Test gets FDA EUA Authorization

2020.07.26

The Analysis of Performance Report of Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test Evaluated by UK Barts Health

2020.07.10

SARS-CoV-2 IgG/IgM Rapid Qualitative Test from Xiamen Biotime gets excellent evaluation results in European authority agencies’ evaluation

2020.07.09

Biotime Biotechnology gives a hand to prevent and control COVID-19 disease around the world

2020.07.09

BIG NEWS: Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test obtained legal export qualification!

2020.07.08

Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test got excellent performance results compared with other maunfacturers in the evaluation study of Amiens University Medical Center in France !

2020.07.07

Biotime has successfully attended CACLP held in NanChang.

2019.03.25

Congratulation: Biotime has got the NMPA of 6 quality control products

2019.03.02

Welcome Director Bin Wang of China Chest Pain Center Regional Certification Center(Xiamen) visited Biotime

2018.12.29

Welcome Academician Lansun Zheng

2018.11.06

Students of School of Chemistry and Chemical Engineering of Xiamen University exercise in Biotime during summer vacation

2018.07.29

study and training course officially started

2018.05.11

first pre 5 page 1617 total 17 page

© 2016 Xiamen Biotime Biotechnology Co., Ltd. all rights reserved

互联网药品信息服务资格证书[(闽)-非经营性备-2024-0002]

+86-592-68831563-5th Floor, No.188, Pingcheng South Road, Haicang, Xiamen, Fujian,361026,China

WeChat public number

Share